Linking Diet, Inflammation, Gut Microbiota, and Sarcopenia: A Cross-Sectional Study
Recruiting now
Conditions studied: Sarcopenia
In brief
Based on the analysis of dietary characteristics, gut microbiota diversity, and composition, this study investigates the relationships between the dietary inflammatory potential, gut microbiota, and sarcopenia. Furthermore, it explores the mediating role of gut microbiota in the association between the dietary inflammatory index and the risk of sarcopenia. The findings are expected to provide insights into the mechanisms through which dietary inflammation influences the development and progression of sarcopenia, and to offer a basis for dietary and nutritional interventions aimed at preventing or managing this condition.
Key facts
- Study ID
- NCT07211321
- Run by
- Jianhua Ma
- People needed
- 1220
- Starts
- 2024-04-16
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2025-10-07
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Permanent residents of the community aged 60 years or older.
- Continuous residence duration in the community for more than 5 years.
You may not qualify if…
- Taking medications known to affect muscle function (e.g., corticosteroids, protein supplements, muscle enhancers).
- Requiring walking assistance or having severe cognitive impairment that would preclude successful completion of assessments including bioelectrical impedance analysis (BIA), gait speed measurement, and handgrip strength testing.
- Presence of a cardiac pacemaker, which contraindicates BIA measurement.
- Diagnosis of one or more chronic diseases that significantly limit dietary intake.
Where it is running
- Lanzhou university — Lanzhou, Gansu, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.